Auto-trilevel Ventilator for Patients With Overlap Syndrome
Effect of Auto-Trilevel Ventilation on Patients With Overlap Syndrome
1 other identifier
interventional
17
1 country
1
Brief Summary
Obstructive Sleep Apnea Syndrome (OSAS) and chronic obstructive pulmonary disease (COPD) are two diseases that often coexist and are called overlap syndrome(OS). Compared to single OSAS, OS patients are more susceptible to serious hypoxia and hypercapnia especially during sleep, and are much more likely to result in pulmonary hypertension and cor-pulmonal. With a more flexible expiratory positive airway pressure (EPAP), auto-trilevel ventilation may be superior to fixed bilevel positive airway pressure (BiPAP) ventilation in both removing residual obstructive sleep apnea hypopnea events and correcting hypercapnia simultaneously. The overall purpose of this study is to compare the curative effects between fixed BiPAP and auto-trilevel ventilations on OS patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2011
CompletedFirst Submitted
Initial submission to the registry
January 12, 2012
CompletedFirst Posted
Study publicly available on registry
February 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2012
CompletedNovember 27, 2012
November 1, 2012
1.2 years
January 12, 2012
November 26, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
different effects between BiPAP and auto-Trilevel ventilators on OS
The overall purpose of this study is to determine the effects of auto-Trilevel ventilation on patients with overlap syndrome by comparison with BiPAP ventilation. The following parameters are compared such as apnea hypopnea index, lowest SPO2, arousal index, sleep efficiency, PaCO2, daytime sleepiness and so on.
Participants will be observed for the duration of hospital stay, an expected average of 1 weeks
Study Arms (1)
ventilator
OTHERThe comparison of the curative effect on OS between BiPAP and auto-trilevel ventilations
Interventions
Noninvasive ventilation including fixed BiPAP ventilation and auto-trilevel ventilation. Using the same IPAP, treatment include one night with BiPAP ventilation mode 1, one night with BiPAP ventilation mode 2 and one night with auto-trilevel ventilation mode. Each treatment last 8 hours for each night.
Eligibility Criteria
You may qualify if:
- Patient or legal representative of the patient is willing and able to sign an approved informed consent and privacy protection authorization in the United States.
- Subject is \>18 years old.
- Diagnosed overlap syndrome(OSAS and COPD). 4. Expected to tolerate the ventilator therapy .
You may not qualify if:
- Patient is currently enrolled in another clinical study which may confound the result of this study.
- Patient for who inform consent cannot be obtained.
- Patients with a history of cerebrovascular accident within the 6 months prior to this study.
- Patients with acute or chronic renal failure, diabetes and severe lung diseases.
- Patients with unstable angina.
- Patient who is of pregnant or during lactation period.
- Patients with a history of injury or surgery within 6 months prior to the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
xilong zhang, MD
The First Affiliated Hospital with Nanjing Medical University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Department of Respirology, The First Affiliated Hospital of Nanjing Medical University
Study Record Dates
First Submitted
January 12, 2012
First Posted
February 1, 2012
Study Start
August 1, 2011
Primary Completion
October 1, 2012
Study Completion
November 1, 2012
Last Updated
November 27, 2012
Record last verified: 2012-11